First Time Loading...

LogicBio Therapeutics Inc
NASDAQ:LOGC

Watchlist Manager
LogicBio Therapeutics Inc Logo
LogicBio Therapeutics Inc
NASDAQ:LOGC
Watchlist
Price: 5.57 USD 169.08%
Updated: May 14, 2024

P/E
Price to Earnings

-6.9
Current
-1.7
Median
27.4
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-6.9
=
Market Cap
183.6m
/
Net Income
-26.5m
All Countries
Close

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-7.7
2-Years Forward
P/E
-9.1
3-Years Forward
P/E
N/A

See Also

Discover More